Lydie Boussicault

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease

Lydie Boussicault, Sandro Alves, Antonin Lamazière et al. · Brain · 2016 · 186 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Impaired Brain Energy Metabolism in the BACHD Mouse Model of Huntington's Disease: Critical Role of Astrocyte–Neuron Interactions

Lydie Boussicault, Anne‐Sophie Hérard, Noel Y. Calingasan et al. · Journal of Cerebral Blood Flow & Metabolism · 2014 · 60 citations · Full text

Life Sciences, Genetics, Neuroscience +17

The amyloid precursor protein is a conserved Wnt receptor

Tengyuan Liu, Tingting Zhang, Maya Nicolas et al. · eLife · 2021 · 35 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis

Lydie Boussicault, Julien Laffaire, Peter A. Schmitt et al. · Journal of Neuroscience Research · 2020 · 28 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Synaptic scaling up in medium spiny neurons of aged BACHD mice: A slow-progression model of Huntington's disease

Anne B. Rocher, Paolo Gubellini, Nicolas Mérienne et al. · Neurobiology of Disease · 2015 · 25 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16